Skip to content

The Effect of Fluoride Varnish on White Spot Lesion in Clear Aligner Orthodontic Patients

The Effect of Fluoride Varnish on White Spot Lesion in Clear Aligner Orthodontic Patients: Prospective Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06403371
Enrollment
44
Registered
2024-05-07
Start date
2023-06-01
Completion date
2024-10-31
Last updated
2024-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

White Spot Lesion

Keywords

Fluoride varnish, Clear aligners, White spot lesions, Quantitative light induced fluorescence (QLF)

Brief summary

Fluoride varnish is being applied on the teeth surfaces of patients undergoing orthodontic treatment just before receiving their clear aligners. The effect of the varnish was investigated if it can reduce the incidence of enamel demineralization or not.

Detailed description

Background: The preventive effect of fluoride varnish on the development of white spot lesions (WSLs) during clear aligner treatment has not been investigated in the literature. Hence this was the purpose of this study. Material and Methods: This was a prospective double-blinded randomized clinical trial. A total of 44 patients (7 males, 37 females, with a mean age of 20.91 ± 4.56) who sought clear aligner therapy at the postgraduate orthodontic clinics at JUST were recruited and randomly divided equally (n=22 in each group) by a website randomizer. Eligibility criteria included healthy patients of both sexes (age range 14-30 years), Class I malocclusion with mild-to-moderate crowding (≤5 mm), non-extraction treatment plan, and optimum oral hygiene before treatment. Both the patient and the investigator were blinded during the intervention and assessment of outcomes. At (T0) Fluoride varnish was applied to the subjects in Group 1, while normal saline was applied to the subjects in Group 2 as a control. Quantitative light-induced fluorescence (QLF) images were taken at the start of the treatment (T0) and after 4 months (T1). The QLF images were analyzed to assess the primary outcomes: lesion area (Pixels), the mean amount of fluorescence loss (ΔF)% in addition to the number of newly developed lesions.

Interventions

OTHERFluoride varnsh

Fluoride varnish was applied to the teeth surfaces before aligner therapy

OTHERNormal saline

Normal saline was applied to the teeth surfaces before aligner therapy

Sponsors

Jordan University of Science and Technology
CollaboratorOTHER
King Abdullah University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Nor the subjects neither the investigator knew the type of varnish they received. Additionally, the outcome assessor was blinded before making the analysis

Intervention model description

Double blinded randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
16 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects form both sexes * Mild to moderate crowding * Optimum oral hygiene * Maximum of three restored teeth

Exclusion criteria

* Presence of enamel hypoplasia or hypocalcification, * Any salivary gland disease or medication use that affect the salivary flow * Subjects using fluoride other than 1450 ppm fluoride toothpaste.

Design outcomes

Primary

MeasureTime frameDescription
Average lesion fluorescence loss (∆F%)4 monthsIt reflects amount of mineral loss
Maximum lesion fluorescence loss (∆F-max%)4 monthsIt measures the deepest point of the lesion (in relation to sound enamel) using QLF system in percent
Lesion area4 monthsIt measures white spot lesion area in pixels

Secondary

MeasureTime frameDescription
Plaque measurement4 monthsIt measures the amount of plaque on teeth surfaces in percent using QLF system

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026